Latest News
Latest news from CeBioR
Latest news from CeBioR - 0 articles matching your search
Latest news from CeBioR - 1 article matching your search
Latest news from CeBioR - {{numberOfPosts}} articles matching your search
External media releases
Scientists discover blood sample detection method
Scientists discover blood sample detection method for multiple sclerosis, the process will avoid invasive, painful process of collecting fluid from brain and spine
Blood Sample Detection for Multiple Sclerosis
A method for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research team.
Team Develops Blood Test for Diagnosing MS
University of Huddersfield researchers have developed a blood test for diagnosing Multiple Sclerosis that avoids the invasive, painful process of collecting fluid from the brain and spine.
ELF identifies hits for a new drug target
European Lead Factory (ELF) project has identified novel small molecules that might be transformed into a new medical treatment for depression and pain.
Innovative screen for depression and pain target
Having discovered an interesting protein involved in depression and pain, Dr Patrick McHugh, University of Huddersfield, wanted to access chemical tools to further explore its role and action.
Novel Drug Target Identified for Depression & pain
Pioneering ideas to improve antidepressant therapies are greatly required since existing antidepressants are moderately effective and the response rate in patients suffering from depression is approximately less than 50%.
Tackling unmet medical needs
Exciting new hits for a novel drug target involved in depression and pain unveiled in the ELF
Tackling unmet medical needs
Exciting new hits for a novel drug target involved in depression and pain unveiled in the EU Lead Factory
New £1 million drugs research centre launched
Drugs researchers have launched a £1 million project at the University of Huddersfield. The new Centre for Biomarker Research (CeBioR) aims to speed up the development of new drugs for a range of conditions and diseases.
Researchers seek new form of antidepressant
SCIENTISTS at the University of Huddersfield led by Dr Patrick McHugh (pictured right) have embarked on a project that could lead to a more effective treatment for depression.
New £1 million research centre up and running
New £1 million research centre up and running to create drugs for cancer, dementia and chronic pain
£1m research centre to create new drugs
Matched funding enables the University of Huddersfield to create the Centre for Biomarker Research
New Centre for Biomarker Research
New Centre for Biomarker Research Launched at the University of Huddersfield
New alpha-synuclein and apoE research paper
Effects of different isoforms of apoE on aggregation of the α‐synuclein protein implicated in Parkinson’s disease
Research on apoE levels shed light on Parkinson’s
Dr Patrick McHugh joins team working on the potential role that alpha-synuclein protein plays in Parkinson’s disease
‘Pain research study needs you!’
‘Researchers wish to hear from people over the age of 18 who DO NOT suffer from chronic pain (> 3 months) to comprise a control group for a research project’
Hud Scientist wins British Pain Clulow Award
“...pain is a highly subjective phenomenon and sensitivities vary from patient to patient...”
Bidding to solve mystery of unexplained pain
University scientist Dr Patrick McHugh is on a mission to help doctors treat one of the least understood but most widespread causes of suffering